Home/Filings/4/0001209191-18-004656
4//SEC Filing

Unninayar Kamalam 4

Accession 0001209191-18-004656

CIK 0001373707other

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 7:48 PM ET

Size

5.6 KB

Accession

0001209191-18-004656

Insider Transaction Report

Form 4
Period: 2018-01-17
Unninayar Kamalam
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Unit

    2018-01-17+40,00040,000 total
    Common Stock (40,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of Tetraphase Pharmaceuticals, Inc. for no consideration.
  • [F2]These restricted stock units shall be earned upon achievement of certain performance conditions and, if earned, shall vest on January 31, 2021.

Issuer

TETRAPHASE PHARMACEUTICALS INC

CIK 0001373707

Entity typeother

Related Parties

1
  • filerCIK 0001720065

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 7:48 PM ET
Size
5.6 KB